PAG
NVO

Private Advisor Group’s Novo Nordisk NVO Stock Holding History

Private Advisor Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$23.7K – 2721
2025
Q3 		$23.7K Buy
+2,000
New +$117K ﹤0.01% 2490

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Private Advisor Group's NVO Position: Q2 2026 in Review

Private Advisor Group reduced its Novo Nordisk (NVO) stake by 22% in Q2 2026, selling an estimated $667K and leaving 54,474 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #894.

Private Advisor Group first reported a position in NVO in Q4 2013 and has held it in 51 quarters since. The position peaked at $13.4M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Private Advisor Group held 54,474 shares of Novo Nordisk worth $2.61M as of Q2 2026.
  • Private Advisor Group sold 15,526 Novo Nordisk shares in Q2 2026, an estimated $667K.
  • Novo Nordisk made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #894 holding.
  • Private Advisor Group first reported a position in Novo Nordisk in Q4 2013 and has held it in 51 quarters since.
  • Private Advisor Group's Novo Nordisk position peaked at $13.4M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.